Literature DB >> 7643867

Deficiency of laminin alpha 2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy.

Y K Hayashi1, R Koga, T Tsukahara, H Ishii, T Matsuishi, Y Yamashita, I Nonaka, K Arahata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7643867     DOI： 10.1002/mus.880180918

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  7 in total

1.  Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Peter B Kang; Leslie Morrison; Susan T Iannaccone; Robert J Graham; Carsten G Bönnemann; Anne Rutkowski; Joseph Hornyak; Ching H Wang; Kathryn North; Maryam Oskoui; Thomas S D Getchius; Julie A Cox; Erin E Hagen; Gary Gronseth; Robert C Griggs
Journal:  Neurology       Date:  2015-03-31       Impact factor: 9.910

Review 2.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry.

Authors:  R Herrmann; V Straub; K Meyer; T Kahn; M Wagner; T Voit
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

Review 4.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

5.  Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan.

Authors:  Wen-Chen Liang; Xia Tian; Chung-Yee Yuo; Wan-Zi Chen; Tsu-Min Kan; Yi-Ning Su; Ichizo Nishino; Lee-Jun C Wong; Yuh-Jyh Jong
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

6.  A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese Patient.

Authors:  Akatsuki Kubota; Hiroyuki Ishiura; Jun Mitsui; Kaori Sakuishi; Atsushi Iwata; Tomotaka Yamamoto; Ichizo Nishino; Shoji Tsuji; Jun Shimizu
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

7.  Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.

Authors:  J T Vilquin; I Kinoshita; B Roy; M Goulet; E Engvall; F Tomé; M Fardeau; J P Tremblay
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.